Literature DB >> 17721294

An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops.

George W Ousler1, Clifford Michaelson, Mike T Christensen.   

Abstract

PURPOSE: To report the performance of an artificial tear containing propylene glycol and polyethylene glycol as active demulcents with hydroxypropyl-guar as a gelling agent (Systane Lubricant Eye Drops; Alcon, Fort Worth, TX) and compare it with that of 2 artificial tears containing carboxymethylcellulose (Refresh Tears and Refresh Endura Lubricant Eye Drops; Allergan, Irvine, CA).
METHODS: This was a single-center, 3-visit, randomized, double-masked crossover study that evaluated the effect of Systane versus Refresh Tears and Refresh Endura using tear film breakup time (TFBUT) and ocular protection index (OPI) in subjects with dry eye (n = 50). TFBUT values (5, 10, 15, 20, 30, 45, and 60 minutes after instillation) divided by interblink interval (IBI) yielded OPI scores.
RESULTS: Systane significantly improved TFBUT at 5, 10, 15, 20, and 60 minutes versus Refresh Tears and at 5, 10, 15, 20, and 30 minutes versus Refresh Endura. Systane OPI scores were significantly higher than Refresh Tears at 15 and 30 minutes and than Refresh Endura at 5 minutes.
CONCLUSIONS: This study suggests that Systane Lubricant Eye Drops was more effective than Refresh Tears at prolonging TFBUT up to 20 minutes after instillation and more effective than Refresh Endura at prolonging TFBUT up to 30 minutes after instillation. These data show that Systane is an effective first-line dry eye therapy and a superior ocular surface protector compared with Refresh Endura and Refresh Tears in the sample test population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721294     DOI: 10.1097/ICO.0b013e3180de1c38

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  19 in total

1.  Tear film images and breakup analyzed using fluorescent quenching.

Authors:  P Ewen King-Smith; Padmapriya Ramamoorthy; Richard J Braun; Jason J Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-05       Impact factor: 4.799

Review 2.  Artificial tears potpourri: a literature review.

Authors:  Majid Moshirfar; Kasey Pierson; Kamalani Hanamaikai; Luis Santiago-Caban; Valliammai Muthappan; Samuel F Passi
Journal:  Clin Ophthalmol       Date:  2014-07-31

3.  Impact on ocular surface evaporation of an artificial tear solution containing hydroxypropyl guar.

Authors:  Eduardo Uchiyama; Mario A Di Pascuale; Igor A Butovich; James P McCulley
Journal:  Eye Contact Lens       Date:  2008-11       Impact factor: 2.018

4.  One month use of Systane improves ocular surface parameters in subjects with moderate symptoms of ocular dryness.

Authors:  Piera Versura; Vincenzo Profazio; Emilio C Campos
Journal:  Clin Ophthalmol       Date:  2008-09

5.  Efficacy and safety of chondroitin sulfate/xanthan gum versus polyethylene glycol/propylene glycol/hydroxypropyl guar in patients with dry eye.

Authors:  Juan Francisco Llamas-Moreno; Leopoldo Martín Baiza-Durán; Laura Ray Saucedo-Rodríguez; José Félix Alaníz-De la O
Journal:  Clin Ophthalmol       Date:  2013-05-29

6.  Systane lubricant eye drops in the management of ocular dryness.

Authors:  Umberto Benelli
Journal:  Clin Ophthalmol       Date:  2011-06-10

7.  Measurement of ocular surface protection under natural blink conditions.

Authors:  Richard Abelson; Keith J Lane; Endri Angjeli; Patrick Johnston; George Ousler; Douglas Montgomery
Journal:  Clin Ophthalmol       Date:  2011-09-22

8.  Etiology, prevalence, and treatment of dry eye disease.

Authors:  Johnny L Gayton
Journal:  Clin Ophthalmol       Date:  2009-07-14

9.  A single-center study evaluating the effect of the controlled adverse environment (CAE(SM)) model on tear film stability.

Authors:  Richard Abelson; Keith J Lane; John Rodriguez; Patrick Johnston; Endri Angjeli; George Ousler; Douglas Montgomery
Journal:  Clin Ophthalmol       Date:  2012-11-13

10.  Validation and verification of the OPI 2.0 System.

Authors:  Richard Abelson; Keith J Lane; John Rodriguez; Patrick Johnston; Endri Angjeli; George Ousler; Douglas Montgomery
Journal:  Clin Ophthalmol       Date:  2012-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.